THB Asset Management’s Trinity Biotech TRIB Stock Holding History

THB Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-55,555	Closed	-$3.18M	–	204
2015 Q3	$3.18M	Sell	55,555 -69,761	-56%	-$5.61M	0.31%	115
2015 Q2	$11.3M	Sell	125,316 -2,175	-2%	-$188K	0.86%	28
2015 Q1	$12.3M	Sell	127,491 -15,486	-11%	-$1.43M	0.86%	23
2014 Q4	$12.5M	Buy	142,977 +8,705	+6%	+$750K	0.83%	27
2014 Q3	$12.3M	Buy	134,272 +30,823	+30%	+$3.34M	0.85%	23
2014 Q2	$11.9M	Buy	103,449 +27,780	+37%	+$3.29M	0.74%	39
2014 Q1	$9.17M	Buy	75,669 +33,711	+80%	+$4.42M	0.55%	73
2013 Q4	$5.27M	Buy	41,958 +7,128	+20%	+$856K	0.29%	140
2013 Q3	$3.79M	Buy	+34,830	New	+$3.4M	0.24%	156

Other funds holding TRIB

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

THB Asset Management's TRIB Position: Q4 2015 in Review

THB Asset Management sold out of Trinity Biotech (TRIB) in Q4 2015, closing a stake of 55,555 shares — an estimated $3.18M sold.

THB Asset Management first reported a position in TRIB in Q3 2013 and held it in 9 quarters. The position peaked at $12.5M in Q4 2014. 82 funds tracked by Wall St. Rank hold TRIB as of Q4 2015.

THB Asset Management reported no remaining Trinity Biotech position as of Q4 2015 after selling out during the quarter.
THB Asset Management sold 55,555 Trinity Biotech shares in Q4 2015, an estimated $3.18M.
THB Asset Management first reported a position in Trinity Biotech in Q3 2013 and held it in 9 quarters.
THB Asset Management's Trinity Biotech position peaked at $12.5M in Q4 2014.
82 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2015.

Based on THB Asset Management's 13F filing for Q4 2015, filed 12 Jan 2016.